Chondrosarcoma Clinical Trials

45 clinical trials for Chondrosarcoma across international registries, including 12 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration — RECRUITING · PHASE2
• IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors — RECRUITING · PHASE1
• Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas — RECRUITING
• Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone — RECRUITING
• Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas — RECRUITING · NA
• A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning — RECRUITING · NA
• Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery — RECRUITING
• Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base — RECRUITING · NA
• PET-imaging of Two Vartumabs in Patients With Solid Tumors — RECRUITING · PHASE1
• Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy — RECRUITING · NA
• A PHASE 3, MULTICENTER, DOA PHASE 3, MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF IVOSIDENIB IN PARTICIPANTS = 18 YEARS OF AGE WITH LOCALLY ADVANCED OR METASTATIC CONVENTIONAL CHONDROSARCOMA WITH AN IDH1 MUTATION, UNTREATED OR PREVIOUSLY — RECRUITING · PHASE3
• Image Assisted Optimization of Proton Radiation Therapy in Chordomas and Chondrosarcomas — RECRUITING
• Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations — ACTIVE_NOT_RECRUITING · PHASE1
• Tazemetostat Expanded Access Program for Adults With Solid Tumors — TERMINATED
• A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE2
• Long-Term Longitudinal QoL in Patients Undergoing EEA — ACTIVE_NOT_RECRUITING
• AG-120 in People With IDH1 Mutant Chondrosarcoma — ACTIVE_NOT_RECRUITING · PHASE2
• Proton Beam Therapy for Chondrosarcoma — ACTIVE_NOT_RECRUITING · PHASE2
• BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast — OTHER
• Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation — COMPLETED · PHASE1
• Clear Cell Chondrosarcoma in Italy — ACTIVE_NOT_RECRUITING · NA
• Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b Trial — ACTIVE_NOT_RECRUITING · PHASE1
• Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers — TERMINATED · PHASE1
• The Registry of Oncology Outcomes Associated With Testing and Treatment — COMPLETED
• Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI — COMPLETED · PHASE2
• Understanding Engagement Trends in Chondrosarcoma Clinical Trials — NOT_YET_RECRUITING
• Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma — COMPLETED · PHASE2
• A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma — OTHER · PHASE2
• A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g) — TERMINATED · PHASE2
• A PHASE 2 STUDY OF ANTI-PD-L1 ANTIBODY (ATEZOLIZUMAB) IN CHONDROSARCOMA AND CLEAR CELL SARCOMA — NOT_YET_RECRUITING · PHASE2
• Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation — COMPLETED · PHASE1
• Metformin And Chloroquine in IDH1/2-mutated Solid Tumors — COMPLETED · PHASE1
• Trial of Dasatinib in Advanced Sarcomas — COMPLETED · PHASE2
• Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors — COMPLETED · PHASE2
• Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma — COMPLETED · PHASE1
• Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery — COMPLETED · PHASE2
• A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma — OTHER · PHASE2
• A Phase II Study of EVEROLIMUS in Patients With Primary or Relapsed Chondrosarcomas — SUSPENDED · PHASE2
• Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical Spine — COMPLETED · PHASE1
• Low Grade Chondrosarcoma Versus Enchondroma — COMPLETED
• Trial of Nilotinib and Adriamycin as Treatment in Liposarcomas and Leiomyosarcomas of Retroperitoneum — OTHER · PHASE1
• S9624 Ifosfamide in Treating Patients With Meningeal Tumors — TERMINATED · PHASE2
• 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma — COMPLETED · PHASE1
• IPI-926 Extension Protocol for Continuation of Treatment With IPI-926 — COMPLETED · NA
• Trial of Proton Versus Carbon Ion Radiation Therapy in Patients With Low and Inter-mediate Grade Chondrosarcoma of the Skull Base — OTHER · PHASE3

Refine this search